CCCC · Company research

C4 Therapeutics, Inc. (CCCC): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20262.82$392,722,238.83331448238.825———63.83651476349154751.6765304948409158—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.